Article
High response rate to PD-1 blockade in desmoplastic melanomas.
Nature - 18 Jan 2018
Eroglu Zeynep, Zaretsky Jesse M, Hu-Lieskovan Siwen, Kim Dae Won, Algazi Alain, Johnson Douglas B, Liniker Elizabeth, Ben Kong, Munhoz Rodrigo, Rapisuwon Suthee, Gherardini Pier Federico, Chmielowski Bartosz, Wang Xiaoyan, Shintaku I Peter, Wei Cody, Sosman Jeffrey A, Joseph Richard W, Postow Michael A, Carlino Matteo S, Hwu Wen-Jen, Scolyer Richard A, Messina Jane, Cochran Alistair J, Long Georgina V, Ribas Antoni
Abstract excerpt
Desmoplastic melanoma is a rare subtype of melanoma characterized by dense fibrous stroma, resistance to chemotherapy and a lack of actionable driver mutations, and is highly associated with ultraviolet light-induced DNA damage. We analysed sixty patients with advanced desmoplastic melanoma who had been treated with antibodies to block programmed cell death 1 (PD-1) or PD-1 ligand (PD-L1). Objective tumour...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
